Item no. |
HY-101193-5mg |
Manufacturer |
MedChem Express
|
CASRN |
15442-64-5 |
Amount |
5 mg |
Quantity options |
10 mM/1 mL
10 mM x 1 mL
10 mg
25 mg
50 mg
5 mg
|
Category |
|
Type |
Inhibitors |
Specific against |
other |
Purity |
99.87 |
Formula |
C34H32N4O4Zn |
Citations |
[1]Park C, et al. Protective Effect of Phloroglucinol on Oxidative Stress-Induced DNA Damage and Apoptosisthrough Activation of the Nrf2/HO-1 Signaling Pathway in HaCaT Human Keratinocytes. Mar Drugs. 2019 Apr 13;17(4). [2]Mwangi MN, et al. Diagnostic utility of zinc protoporphyrin to detect iron deficiency in Kenyan pregnant women. BMC Med. 2014 Nov 26;12:229. [3]Nowis D, et al. Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice. BMC Cancer. 2008 Jul 11;8:197. |
Smiles |
OC(CCC1=C(C=C2[N]3=C4C(C)=C2CCC(O)=O)[N-]([Zn+2]35[N]6=C7C=C(C(C=C)=C8C)[N-]5C8=C4)C(C=C6C(C=C)=C7C)=C1C)=O |
ECLASS 10.1 |
32160490 |
ECLASS 11.0 |
32160490 |
UNSPSC |
12000000 |
Alias |
Zn(II)-protoporphyrin IX, ZnPP, Zinc Protoporphyrin-9 |
Shipping condition |
Cool pack |
Available |
|
Manufacturer - Type |
Reference compound |
Manufacturer - Applications |
COVID-19-immunoregulation |
Manufacturer - Targets |
Apoptosis; Endogenous Metabolite; Reactive Oxygen Species |
Shipping Temperature |
Blue Ice |
Storage Conditions |
-20°C (Powder, sealed storage, away from moisture) |
Molecular Weight |
626.02 |
Product Description |
Zinc Protoporphyrin (Zn(II)-protoporphyrin IX) is an orally active and competitive heme oxygenase-1 (HO-1) inhibitor and markedly attenuates the protective effects of Phloroglucinol (PG) against H2O2[1]. Zinc Protoporphyrin is used as a screening marker of iron deficiency in individual pregnant women and children, but also to assess population iron status in combination with haemoglobin concentration[2]. Zinc Protoporphyrin has anti-cancer activity[3]. |
Manufacturer - Research Area |
Cancer; Metabolic Disease; Cardiovascular Disease |
Solubility |
DMSO : 20.83 mg/mL (ultrasonic; warming; heat to 60°C) |
Manufacturer - Pathway |
Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB |
Isoform |
Human Endogenous Metabolite |
Clinical information |
No Development Reported |
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.